Interstitial fibrosis of the heart contributes to cardiac dysfunction and morbidity associated with heart failure. The specific cellular origins and molecular pathogenesis of cardiac fibrosis are not well defined, but the end state of fibrosis includes increased expression of extracellular matrix (ECM) proteins by interstitial fibroblasts. During heart development, the interstitial fibroblasts arise from epicardial-derived cells (EPDCs) that invade the myocardium, differentiate, and synthesize ECM ofthe fibrous cardiac matrix. There is recent evidence that EPDCs are activated and recapitulate developmental mechanisms in adult cardiac injury and pathologic fibrosis. Wnt/p-catenin signaling is required for epicardial development, but its role in fibroblast cell lineage development or cardiac fibrosis has not been examined. We hypothesize that Wnt/p-catenin signaling promotes normal development of interstitial fibroblasts and also contributes to pathologic interstitial fibrosis in adult cardiovascular disease. Using constructs and disease models developed by Projects 1 and 3, as well as in our own laboratory, the three Specific Aims are designed to test the necessity and sufficiency of the roles played by Wnt/p-catenin fibroblast signaling during development and cardiac disease.
Specific Aim 1 will determine if Wnt/p-catenin signaling promotes interstitial fibroblast lineage differentiation and ECM formation during development in vivo.
Aim 2 will determine if Wnt/p-catenin signaling promotes maladaptive fibrotic disease and if Wnt pathway inhibition is sufficient to prevent the progression of fibrosis and heart failure in adulthood.
Aim 3 will examine the intersection of Wnt/p-catenin and TGFp/Smad2/3 signaling pathways in the induction and progression of cardiac fibrosis. These in vivo mechanistic studies will be used to dissect the molecular contributions of Wnt/p-catenin signaling to cardiac fibroblast lineage, development and the pathogenesis of interstitial fibrosis in cardiovascular disease. The long-term goal of the proposed studies is to identify new therapeutic targets for the treatment and management of maladaptive cardiac fibrosis and subsequent heart failure. 1

Public Health Relevance

Cardiac fibroblasts are a major cell type in the heart but the roles they play in terms of disease development are largely unexplored. We hypothesize that specific signaling processes that are critical for normal development play an important role in defining these cells. We also want to test if these processes are more generally involved irji cardiac disease and heart failure. Definitive proof of these ideas will identify new therapeutic possibilities for the treatment of cardiac disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL069779-11
Application #
8460272
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-05-31
Support Year
11
Fiscal Year
2013
Total Cost
$284,482
Indirect Cost
$92,830
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Sandri, Marco; Robbins, Jeffrey (2014) Proteotoxicity: an underappreciated pathology in cardiac disease. J Mol Cell Cardiol 71:3-10
Molkentin, Jeffery D (2014) Letter by Molkentin regarding article, "The absence of evidence is not evidence of absence: the pitfalls of Cre Knock-Ins in the c-Kit Locus". Circ Res 115:e21-3
Gupta, Manish K; Robbins, Jeffrey (2014) Post-translational control of cardiac hemodynamics through myosin binding protein C. Pflugers Arch 466:231-6
Mun, Ji Young; Previs, Michael J; Yu, Hope Y et al. (2014) Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism. Proc Natl Acad Sci U S A 111:2170-5
Wang, Xuejun; Robbins, Jeffrey (2014) Proteasomal and lysosomal protein degradation and heart disease. J Mol Cell Cardiol 71:16-24
Gupta, Manish K; Gulick, James; Liu, Ruijie et al. (2014) Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes. Circ Res 115:721-9
Sengupta, Arunima; Kalinichenko, Vladimir V; Yutzey, Katherine E (2013) FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation. Circ Res 112:267-77
Chakraborty, Santanu; Sengupta, Arunima; Yutzey, Katherine E (2013) Tbx20 promotes cardiomyocyte proliferation and persistence of fetal characteristics in adult mouse hearts. J Mol Cell Cardiol 62:203-13
Braitsch, Caitlin M; Kanisicak, Onur; van Berlo, Jop H et al. (2013) Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J Mol Cell Cardiol 65:108-19
Razzaque, Md Abdur; Gupta, Manish; Osinska, Hanna et al. (2013) An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure. Circ Res 113:553-61

Showing the most recent 10 out of 77 publications